# Democratic Republic of Congo

Type: country

Source: Biotech Intelligence Brief — https://getbiobrief.com/entity/democratic-republic-of-congo
Canonical HTML page: https://getbiobrief.com/entity/democratic-republic-of-congo

## Recent coverage (4 stories)

### Bundibugyo Ebola Strain with No Vaccine Kills 6-Month-Old, Cases Top 894
2026-07-12 10:21:15 · Sentiment: Strongly negative · Impact: 8/10 · Sources: 3

The Bundibugyo ebolavirus outbreak in Congo has no approved vaccine or treatment, creating a pressing unmet medical need. With 894 cases and over 200 deaths, the crisis could accelerate biopharma R&D for neglected filovirus strains.
Full story: https://getbiobrief.com/story/bundibugyo-ebola-no-vaccine-outbreak-bio

### 75 Medics Infected in Congo Ebola Outbreak: Urgent Call for New Vaccines
2026-07-12 10:11:15 · Sentiment: Strongly negative · Impact: 8/10 · Sources: 2

75 healthcare workers infected with the Ebola Bundibugyo strain in DRC expose critical gaps in vaccine coverage and trial infrastructure, pressuring biopharma to accelerate strain-specific countermeasures.
Full story: https://getbiobrief.com/story/congo-ebola-medic-infections-bio

### 2 experimental drugs enter clinical trial for rare Ebola strain after 500+ deaths
2026-07-11 19:54:59 · Sentiment: Positive · Impact: 8/10 · Sources: 7

With no approved therapies for the Bundibugyo Ebola strain and an outbreak surpassing 500 fatalities, two candidate drugs have begun a clinical trial, and a prophylactic agent trial is imminent. The collaborative effort signals a pivot toward rapid, integrated R&D for neglected filoviruses.
Full story: https://getbiobrief.com/story/bio-ebola-drug-trials-bundibugyo

### 10 Deaths in One Week: Ebola Surge in Congo Camp Pressures Vaccine & Diagnostic Pipeline
2026-06-28 12:36:07 · Sentiment: Strongly negative · Impact: 8/10 · Sources: 3

At least 30 deaths with Ebola symptoms in a crowded DRC camp highlight untreated spread and demand for rapid point-of-care diagnostics and expanded vaccine access. With 5 million displaced at risk, biopharma firms face calls to accelerate countermeasure deployment.
Full story: https://getbiobrief.com/story/ebola-congo-camp-vaccine-pressure

---
This page is a machine-readable summary. Sentiment measures the directional read of each development for this entity, not the tone of the reporting; impact weights consequence, not syndication reach. See https://getbiobrief.com/guides/methodology for the full editorial methodology.